Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company details domestic medicinal cannabis production

Canndeo is building a domestic medicinal cannabis production and supply capability.
The Hydroponics Company details domestic medicinal cannabis production
Canndeo has received a cannabis research licence

The Hydroponics Company (ASX:THC) through its wholly-owned medicinal cannabis subsidiary, Canndeo Limited, is building a domestic medicinal cannabis production and supply capability.

This is being achieved through the licensing program established under the Narcotic Drugs Act 1967.

There are three relevant licences issued by the Office of Drug Control:

- A cannabis research licence allows the production of cannabis strains for research into medicinal use;

- A medicinal cannabis licence allows either cultivation or production or both of medicinal cannabis plants; and

- A manufacturing licence allows the manufacture of cannabis and cannabis extract into medicinal cannabis.

Canndeo received a cannabis research licence on 6 July 2017, and its application for a medicinal cannabis licence is progressing in its assessment and a manufacturing licence application is currently under development.

THC said that it will advise the market when the licences are granted and also with regard its domestic medicinal cannabis production and supply capability.

View full THC profile View Profile

The Hydroponics Company Ltd Timeline

Related Articles

e-Therapeutics
August 17 2017
E-Therapeutics’ network-driven drug discovery platform looks at the broader interactions within disease mechanisms
shutterstock_244380844.jpg
April 21 2017
The company said it is preparing to meet with US regulators on plans for a phase III trial of its treatment for victims of stroke, while it wants to expand its ophthalmology study
Paradigm Biopharmaceuticals: Access latest PPT from Proactive's CEO Sessions
May 19 2017
Paul Rennie talked timeline to clinical trial results with investors.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use